Eplerenone Tablet, Coated
Product Images NDC 42291-455

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Eplerenone (NDC 42291-455). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

25 (454 90)

Each tablet contains 25 mg eplerenone. The tablets are stored in child-resistant containers at a temperature of 25°C (77°F) with excursions allowed. They are manufactured by Blicphama i Famaciics, SA S in Portugal and sold under the brand name Eplerenone Erisissit.*

FDA Label Image

50 (455 90)

Each tablet of this medication called Eplerenone contains 50mg of the active ingredient. The usage instructions and other important information can be found in the accompanying prescription form. The medication is manufactured by Bepharms st Famacéutc, SA and should be stored at 25 degrees Celsius. The contact address of the manufacturer is also provided in the text.*

FDA Label Image

Chemical Structure (Eplerenone 01)

FDA Label Image

Figure 1 (Eplerenone 02)

The given text is describing the cumulative incidence of a medication named Eplerenone. The statistical information and numbers are representing the effectiveness of this medication in a particular study. The study shows that Eplerenone has a cumulative incidence rate of 0.85 with a 95% confidence interval between 0.75-0.096. The rest of the text is not readable.*

FDA Label Image

Figure 2 (Eplerenone 03)

FDA Label Image

Figure 3 (Eplerenone 04)

FDA Label Image

Figure 4 (Eplerenone 05)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.